Growth Metrics

ImmunityBio (IBRX) Tax Provisions (2015 - 2026)

ImmunityBio (IBRX) reported Tax Provisions of $9000.0 for Q1 2026, up 104.5% year-over-year from $4401.0 in Q1 2025, and up 106.67% on a QoQ basis from -$135000.0 in Q4 2025.

ImmunityBio (IBRX) has 11 years of Tax Provisions data on file, last reported at $9000.0 in Q1 2026.

  • Quarterly Tax Provisions rose 104.5% year-over-year to $9000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $139000.0 (up 169.5% YoY) and the FY2025 annual result came in at -$135000.0, changed N/A from the prior year.
  • Tax Provisions climbed to $9000.0 in Q1 2026 per IBRX's latest filing, from -$135000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $300000.0 in Q2 2025 and bottomed at -$200000.0 in Q1 2025.
  • The 4-year median for Tax Provisions is -$35000.0 (2025), against an average of -$9571.4.
  • The widest annual swing landed in 2022, when Tax Provisions soared 3300.0%; it then tumbled 217.65% in 2023.
  • Tracing IBRX's Tax Provisions over 4 years: stood at $34000.0 in 2022, then plunged by 217.65% to -$40000.0 in 2023, then sank by 237.5% to -$135000.0 in 2025, then jumped by 106.67% to $9000.0 in 2026.
  • Per Business Quant, the three latest IBRX Tax Provisions figures stand at $9000.0 (Q1 2026), -$135000.0 (Q4 2025), and -$35000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -11.20 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -859,000.00
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 221.50 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - 216,000.00
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 104.00 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 15.66 Mn
10 ImmunityBio 7.72 Bn 7.34 Bn 43.97 Mn 9,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 9,000.00
Dec 31, 2025 -135,000.00
Sep 30, 2025 -35,000.00
Jun 30, 2025 300,000.00
Mar 31, 2025 -200,000.00
Dec 31, 2023 -40,000.00
Dec 31, 2022 34,000.00
Dec 31, 2021 1,000.00
Jun 30, 2021 2,000.00
Mar 31, 2021 6,000.00
Dec 31, 2020 -209,000.00
Sep 30, 2020 -1.70 Mn
Jun 30, 2020 45,000.00
Mar 31, 2020 18,000.00
Dec 31, 2019 -71,000.00
Jun 30, 2019 2,000.00
Mar 31, 2019 -36,000.00
Dec 31, 2018 378,000.00
Sep 30, 2018 -128,000.00
Jun 30, 2018 -123,000.00
Mar 31, 2018 -124,000.00
Dec 31, 2017 -172,000.00
Sep 30, 2017 -99,000.00
Jun 30, 2017 -124,000.00
Mar 31, 2017 -98,000.00
Dec 31, 2016 -149,000.00
Sep 30, 2016 -52,000.00
Jun 30, 2016 -228,000.00
Mar 31, 2016 -143,000.00
Mar 31, 2015 1,000.00